Grant: Operating Grant
McMaster University
$100,000.00
An integrative study of skeletal muscle disuse-induced atrophy in humans
EF 2015-16
Résumé
During periods of bed rest or physical inactivity (i.e., illness) our limbs, particularly our legs, are in a state of disuse and we can lose a significant amount of muscle. A good example of this phenomenon is when a cast is removed from an individual's leg or arm after days or weeks and their limb is visibly smaller. This process is termed disuse-atrophy and it can have a significant negative impact upon our ability to perform everyday tasks. It can also result, if long enough, in the development of serious health complications such as type 2 diabetes. As a result, the development of treatments to counteract muscle loss during disuse is currently a topic of intense research and debate. Unfortunately, the main barrier preventing researchers from developing viable therapies to treat muscle disuse atrophy is a lack of understanding as to why it actually occurs. Some scientists argue that during disuse our muscle proteins are broken down at a rate faster than they can be newly made. Others, propose instead that disuse of muscle results in our muscles being less able to make new proteins. Quite possibly, it could be a result of both greater rates of protein breakdown and lower rates of protein synthesis. Regrettably, despite many years of research, we do not know the answer to this question. However, knowing the answer to this question is critical as the type of treatment used to slow the loss of muscle mass during disuse rests on knowing the answer. Using a broad range of state-of-the-art techniques we aim to be the first to measure muscle protein breakdown and muscle protein synthesis during a time course of disuse in humans. After establishing this time course we will examine the impact of therapeutic treatments in offsetting muscle disuse atrophy. Our study will provide valuable, and desperately needed information for clinicians, pharmaceutical companies, and the scientific community alike.
Programme
Operating Grant
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
333001
Name
Phillips Stuart M
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Musculoskeletal Health and Arthritis
Theme2
Biomedical
Prcname2
Movement & Exercise
Projecttitle
An integrative study of skeletal muscle disuse-induced atrophy in humans
Programtype2
Operating Grants
Orgnameinp2
McMaster University
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Operating Grant
Keyworddelim
Immobilization; Inactivity; Mechanistic Target Of Rapamycin; Protein Breakdown; Protein Synthesis; Protein Turnover; Proteolysis; Signaling Protein; Skeletal Muscle; Translation Initiation
Abstract
During periods of bed rest or physical inactivity (i.e., illness) our limbs, particularly our legs, are in a state of disuse and we can lose a significant amount of muscle. A good example of this phenomenon is when a cast is removed from an individual's leg or arm after days or weeks and their limb is visibly smaller. This process is termed disuse-atrophy and it can have a significant negative impact upon our ability to perform everyday tasks. It can also result, if long enough, in the development of serious health complications such as type 2 diabetes. As a result, the development of treatments to counteract muscle loss during disuse is currently a topic of intense research and debate. Unfortunately, the main barrier preventing researchers from developing viable therapies to treat muscle disuse atrophy is a lack of understanding as to why it actually occurs. Some scientists argue that during disuse our muscle proteins are broken down at a rate faster than they can be newly made. Others, propose instead that disuse of muscle results in our muscles being less able to make new proteins. Quite possibly, it could be a result of both greater rates of protein breakdown and lower rates of protein synthesis. Regrettably, despite many years of research, we do not know the answer to this question. However, knowing the answer to this question is critical as the type of treatment used to slow the loss of muscle mass during disuse rests on knowing the answer. Using a broad range of state-of-the-art techniques we aim to be the first to measure muscle protein breakdown and muscle protein synthesis during a time course of disuse in humans. After establishing this time course we will examine the impact of therapeutic treatments in offsetting muscle disuse atrophy. Our study will provide valuable, and desperately needed information for clinicians, pharmaceutical companies, and the scientific community alike.
Competitiondate
201505
Approvedterm2
1 yr 0 mth
Pinamesdelim
Phillips, Stuart M
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $100,000~ $0~